Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ: MRNA )

42.25 -0.92 (-2.13%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
MarketBeat Week in Review – 01/06 - 01/10
Stocks continued to slide after a hot jobs report sent bond yields higher, lowered expectations for future rate cuts, and keeps inflation and earnings in focus 
Via MarketBeat
Topics Bonds Economy Government
Exposures Debt Markets Interest Rates Political
10 Worst Performing Large-Caps Last 12 Months
Here’s this week’s top ten worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up. 
Via Investor's Business Daily
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Spotlight on Moderna: Analyzing the Surge in Options Activity
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Peering Into Moderna's Recent Short Interest
Via Benzinga
"Motley Fool Money" 2025 Stock Market Preview
New year, new market? Motley Fool analysts preview what's in store for investors in 2025, the companies they're excited to watch and the businesses they're worried about. 
Via The Motley Fool
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind. 
Via Benzinga
Topics ETFs
Moderna Shares Spike on H5N1 News—What’s Next for Investors?
MRNA stock surged over 12% on growing bird flu concerns; that rally may not last, but analysts believe the company's pipeline makes the stock a Buy in 2025 
Via MarketBeat
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
Via The Motley Fool
Is Moderna Stock a Buy?
Via The Motley Fool
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
The U.S. stock market experienced a downturn on Tuesday, with the Nasdaq Composite falling by 1.9% and the S&P 500 dropping by 1.1%.. 
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks Sink As Bond Yields Soar, Nvidia Eyes Worst Day In 4 Months, Bitcoin Tumbles To $97,000: What's Driving Markets Tuesday?
Tuesday began as a calm day on Wall Street, but markets swiftly turned negative after the Institute for Supply Management released data highlighting an unexpected surge in price pressures within the... 
Via Benzinga
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike
Moderna, BioNTech and Novavax stocks popped after the CDC noted a recent increase in positive Covid tests. 
Via Investor's Business Daily
Exposures COVID-19
S&P 500, Nasdaq Fall As Economic Data, Bond Yields Weigh
Stocks are mostly lower today, with the S&P 500 Index and Nasdaq Composite Index erasing early-morning gains. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus. The CDC is also reporting high levels of acute respiratory illnesses... 
Via Benzinga
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Investors Look Back at 2024
The S&P 500 had a great year. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Moderna (MRNA) Stock Is Trading Higher
Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory illnesses across the United States. 
Via Benzinga
3 Growth Stocks That Could Skyrocket in 2025 and Beyond
The proverbial planets are aligning for these three companies, and their stocks. 
Via The Motley Fool
10 Worst Performing Large-Caps Last 12 Months
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities
Meet the Newest Stock in the Nasdaq-100. It's Soared 110,600% Since Its IPO and It's Still a Buy Heading Into 2025, According to Wall Street.
Shares of this specialty technology company have gained 141% over the past year, and that could be just the beginning. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
10 Worst Performing Large-Caps Last 12 Months
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities
US Stocks To Open Higher As Wall Street Expects 'Santa Rally' In Shortened Trading Week: MicroStrategy, Palantir, Qualcomm Among Stocks In Focus
U.S. stock futures advanced on Monday as two out of the four major index futures were trading higher in premarket trade. 
Via Benzinga
Large-Cap Stocks In Trouble - Saturday, Dec. 21
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Topics Stocks / Equities
3 Stocks That Could Turn $1,000 into $5,000 by 2030
Via The Motley Fool
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS. 
Via Investor's Business Daily
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Via The Motley Fool
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
Wall Street began Tuesday’s session on a weaker note, with major indices slipping after November's robust retail sales report reignited investor concerns that the Federal Reserve might hold back... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry
Super Micro Computer's stock is trading below its 50-day moving average ahead of its removal from the Nasdaq 100 Index on Dec. 23, 2024. The company faces delisting concerns and is seeking to raise... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.